High risk of autoimmune diseases after COVID-19.

Sharma, Chetan; Bayry, Jagadeesh · Nat Rev Rheumatol · 2023

review · Level V

Where this comes from

Abstract

The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use large cohorts now highlight that SARS-CoV-2 infection is linked to a substantially increased risk of developing a diverse spectrum of new-onset autoimmune diseases.

Medical subject headings